Medical Journals

Abeta Peptides Can Enter the Brain Through a Defective Blood-brain Barrier and Bind Selectively to Neurons.

Authors:
  • Clifford Peter M
  • Zarrabi Shabnam
  • Siu Gilbert
  • Kinsler Kristin J
  • Kosciuk Mary C
  • Venkataraman Venkateswar
  • D’Andrea Michael R
  • Dinsmore Steven
  • Nagele Robert G

From: New Jersey Institute for Successful Aging, University of Medicine and Dentistry of New Jersey/SOM, 2 Medical Center Drive, Stratford, NJ 08084, USA.

Brain research

  • Publish Date: Apr 2007
  • ISSN: 0006-8993
  • Volume: 1142
  • Issue:
  • Pages: 223-36
  • Medium: Print
  • Language: English
  • Citation (JAMA): Clifford Peter M, Zarrabi Shabnam, Siu Gilbert, et al. Abeta Peptides Can Enter the Brain Through a Defective Blood-brain Barrier and Bind Selectively to Neurons.. Brain Res. Apr 2007;1142:223-36

Abstract

We have investigated the possibility that soluble, blood-borne amyloid beta (Abeta) peptides can cross a defective blood-brain barrier (BBB) and interact with neurons in the brain. Immunohistochemical analyses revealed extravasated plasma components, including Abeta42 in 19 of 21 AD brains, but in only 3 of 13 age-matched control brains, suggesting that a defective BBB is common in AD. To more directly test whether blood-borne Abeta peptides can cross a defective BBB, we tracked the fate of fluorescein isothiocyanate (FITC)-labeled Abeta42 and Abeta40 introduced via tail vein injection into mice with a BBB rendered permeable by treatment with pertussis toxin. Both Abeta40 and Abeta42 readily crossed the permeabilized BBB and bound selectively to certain neuronal subtypes, but not glial cells. By 48 h post-injection, Abeta42-positive neurons were widespread in the brain. In the cerebral cortex, small fluorescent, Abeta42-positive granules were found in the perinuclear cytoplasm of pyramidal neurons, suggesting that these cells can internalize exogenous Abeta42. An intact BBB (saline-injected controls) blocked entry of blood-borne Abeta peptides into the brain. The neuronal subtype selectivity of Abeta42 and Abeta40 was most evident in mouse brains subjected to direct intracranial stereotaxic injection into the hippocampal region, thereby bypassing the BBB. Abeta40 was found to preferentially bind to a distinct subset of neurons positioned at the inner face of the dentate gyrus, whereas Abeta42 bound selectively to the population of large neurons in the hilus region of the dentate gyrus. Our results suggest that the blood may serve as a major, chronic source of soluble, exogenous Abeta peptides that can bind selectively to certain subtypes of neurons and accumulate within these cells.

Mesh Headings (Keywords): Aged, Aged, 80 and over, Alzheimer Disease, Amyloid beta-Protein, Animals, Blood-Brain Barrier, Brain, Capillary Permeability, Case-Control Studies, Collagen Type IV, Fluorescent Antibody Technique, Humans, Indoles, Mice, Neurons, Pertussis Toxin, Postmortem Changes, Protein Transport, Time Factors


Check for Full Text / PubMed Unique Identifier (PMID): 17306234


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.